Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Morgan Stanley says selloff in the clean tech industry overdone; upgrades ratings

Broker Morgan Stanley upgraded its view on the clean tech industry, stating the stock selloff caused by concerns of higher interest rate as the main reason to do so. The broker upgraded some of the stocks in the industry, centered around this positive outlook.

Akanksha Vashisht | 19 October 2023

Stifel cuts price target on Colgate despite rating upgrade

Colgate-Palmolive (NYSE: CL), the manufacturer of toothpaste, experienced a 1.4% increase in its stock value, reaching US$71.9, following a rating upgrade by Stifel from 'hold' to 'buy.' Stifel is optimistic about the company's organic sales growth in FY23.

Akanksha Vashisht | 17 October 2023

Needham upgrades AMAT, LRCX to Buy as it expects semiconductor sale volume to rebound in FY24

Broker Needham recently raised its ratings on semiconductor manufacturersApplied Materials (NASDAQ: AMAT) and Lam Research Corp. (NASDAQ: LRCX). Needham upgraded both stocks to ‘buy’ from ‘hold’.

Akanksha Vashisht | 16 October 2023

Target share price gets a boost from BofA rating upgrade

General merchandise retailerTarget Corp. (NYSE: TGT)received a rating upgrade from broker BofA. TGT price rose by around 3% post the rating upgrade from BofA on October 12, 2023.

Akanksha Vashisht | 15 October 2023

Brokers initiate coverage on Neumora Therapeutics with a Buy rating

Biopharmaceutical firmNeumora Therapeutics (NASDAQ: NMRA)received a ‘buy’ rating from brokers shortly after its recent listing on the stock market. The stock debuted on the market last month and its price has declined by 28.5% since then.

Akanksha Vashisht | 12 October 2023

BofA ups target price on on Eli Lilly, stock jumps

Broker BofA increased its price target onEli Lilly and Company (NYSE: LLY), a pharmaceutical firm with its key areas of focus being neuroscience, cancer, and immunology. Eli Lilly’s market cap stood at over US$500 billion on Friday

Akanksha Vashisht | 09 October 2023

RBC initiates Johnson & Johnson with Outperform rating, sets target price at US$178

Brokerage RBC initiated its coverage onJohnson & Johnson (NYSE: JNJ), giving the stock an ‘outperform’ rating. The broker et its price target at US$178, an upside potential of over 13% over Thursday’s closing price.

Akanksha Vashisht | 08 October 2023

UBS raises rating on Fluor Corp.; expects shares to rise by over 35%

Broker UBS raised its rating onFlour Corp. (NYSE: FLR), to ‘buy’ from ‘neutral’. UBS elevated its price target on the construction firm by US$12 to US$47, which marks an upside potential of 36% over FLR’s closing price on Wednesday.

Akanksha Vashisht | 05 October 2023

BMO positive on Structure Therapeutics; expects stock price to shoot up by 40%

DrugmakerStructure Therapeutics (NASDAQ: GPCR) saw its share price rising on October 3, 2023, after broker BMO raised its price target on the company. BMO Capital Markets raised its price target on GPCR from US$40 to US$83, leading the stock price to rise by 1.6% …

Akanksha Vashisht | 04 October 2023

J.P. Morgan upgrades DigitialBridge (NYSE: DBRG) to Overweight. Will other brokers follow suit

REIT firmDigitalBridge (NYSE: DBRG)received a rating upgrade from broker J.P. Morgan before market open on September 28, 2023.

Akanksha Vashisht | 28 September 2023